Eletriptan issues.
Hettiarachchi
Jayasena
J
Sikes
Carolyn
C
D051544:Cytochrome P-450 CYP3A; D065607:Cytochrome P-450 Enzyme Inhibitors; D004347:Drug Interactions; D011307:Drug Prescriptions; D006801:Humans; D007211:Indoles / Q000627:therapeutic use*; D008881:Migraine Disorders / Q000188:drug therapy*; D011759:Pyrrolidines / Q000627:therapeutic use*; D012107:Research Design / Q000592:standards; D017366:Serotonin Receptor Agonists / Q000627:therapeutic use*; D014363:Tryptamines
D065607:Cytochrome P-450 Enzyme Inhibitors; D007211:Indoles; D011759:Pyrrolidines; D017366:Serotonin Receptor Agonists; D014363:Tryptamines; C115647:eletriptan; C104464:CYP3A protein, human; D051544:Cytochrome P-450 CYP3A